Sedia Biosciences To Present And Exhibit At 2014 International AIDS Conference

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Sedia Biosciences Corporation of Portland, Oregon will be presenting its first public results of a new rapid point-of-care HIV incidence assay at the upcoming 20th International AIDS Conference in Melbourne, Australia, July 21-25, 2014. The new assay is expected to augment Sedia’s suite of commercial HIV incidence products and further establish Sedia’s leadership in the development and manufacture of laboratory assays to monitor the epidemic around the world. The presentation, given as a scientific poster, is entitled “Characterization of a rapid HIV-1 incidence assay based on a CDC-developed multi-subtype antigen in a commercial HIV lateral flow assay format.”

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC